| NCT ID | NCT07133724 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Degenerative Lumbar Spine Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-08-01 |
| Primary Completion | 2028-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-08-01 with a primary completion date of 2028-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will integrate wireless wearable sensors, smartphone imaging, and multimodal artificial intelligence (AI) to address the rehabilitation needs of patients with lumbar degeneration. Patients will undergo comprehensive functional assessments, and individualized exercise instruction with real-time feedback will be provided through a smartphone application. The goals of this research are to: (1) develop a multimodal AI-based digital health system combining IMU sensors and smartphone cameras for real-time assessment and interactive rehabilitation training, (2) construct biomechanics- and gait-analysis models to support personalized rehabilitation for patients with lumbar degeneration, and (3) investigate the mechanisms and clinical efficacy of pelvic control exercise training combined with real-time smartphone feedback in improving function and quality of life for aging patients.
Eligibility Criteria
Inclusion Criteria: 1. Age between 50-80 years to capture the typical characteristics of lumbar degeneration in this age group. 2. No history of low back pain lasting more than one week or severe enough to interrupt work within the past year. 3. Normal lumbar functional mobility. 4. Ability to walk independently for more than 10 meters. Exclusion Criteria: 1. Presence of systemic joint diseases such as ankylosing spondylitis, rheumatoid arthritis, or multiple sclerosis, which may significantly affect lumbar mobility and gait patterns. 2. Central nervous system disorders (e.g., spinal cord injury, stroke, or Parkinson's disease) that may influence gait and motor control. 3. Vestibular system disorders, to avoid balance abnormalities interfering with gait testing. 4. History of spinal or lower limb surgery, as postoperative changes may affect the accuracy of gait data. 5. Inability to communicate or follow instructions.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07133724 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Degenerative Lumbar Spine Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07133724 currently recruiting?
Yes, NCT07133724 is actively recruiting participants. Contact the research team at wlhsu@ntu.edu.tw for enrollment information.
Where is the NCT07133724 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT07133724 clinical trial?
NCT07133724 is sponsored by National Taiwan University Hospital. The trial plans to enroll 100 participants.